UNLABELLED: Objective background: The Montreal Cognitive Assessment (MoCA) is a questionnaire that has been developed to help physicians around the world diagnose a patient's cognitive ability. Available in multiple languages and for use in multiple countries worldwide, the goal of this study was to validate the alternate versions 2 and 3 of the French MoCA test to assist physicians in the detection of mild cognitive impairment (MCI), while decreasing the learning effect upon frequent testing. METHODS: A validation study was conducted at the MoCA Clinic and Institute in Québec, Canada. The subject population consisted of 25 patients diagnosed with MCI meeting Petersen criteria and 25 healthy subjects serving as the normal control (NC) group. Three MoCA test versions were administered in the French language in random order within one session. Scores obtained in all three versions in MCI and NC groups were assessed for reliability and consistency from one version to the next. RESULTS: On average, scores obtained in each subject group (MCI and NC) fell within their corresponding diagnostic ranges (score above 26 points for NC patients versus scores below 26 points for MCI patients). Difference in scores observed between the original French MoCA version and the two alternate versions in each subject cohort were minimal and not considered clinically significant. CONCLUSIONS: All three test versions of the French MoCA are considered equivalent in diagnostic reliability and consistency and contribute to decreasing the potential learning effect when patients are required to repeat the test frequently.
UNLABELLED: Objective background: The Montreal Cognitive Assessment (MoCA) is a questionnaire that has been developed to help physicians around the world diagnose a patient's cognitive ability. Available in multiple languages and for use in multiple countries worldwide, the goal of this study was to validate the alternate versions 2 and 3 of the French MoCA test to assist physicians in the detection of mild cognitive impairment (MCI), while decreasing the learning effect upon frequent testing. METHODS: A validation study was conducted at the MoCA Clinic and Institute in Québec, Canada. The subject population consisted of 25 patients diagnosed with MCI meeting Petersen criteria and 25 healthy subjects serving as the normal control (NC) group. Three MoCA test versions were administered in the French language in random order within one session. Scores obtained in all three versions in MCI and NC groups were assessed for reliability and consistency from one version to the next. RESULTS: On average, scores obtained in each subject group (MCI and NC) fell within their corresponding diagnostic ranges (score above 26 points for NC patients versus scores below 26 points for MCI patients). Difference in scores observed between the original French MoCA version and the two alternate versions in each subject cohort were minimal and not considered clinically significant. CONCLUSIONS: All three test versions of the French MoCA are considered equivalent in diagnostic reliability and consistency and contribute to decreasing the potential learning effect when patients are required to repeat the test frequently.
Authors: Valentin Magnon; Frederic Dutheil; Igor Tauveron; Jordan Mille; Julien S Baker; Valentin Brusseau; Laetitia Silvert; Marie Izaute; Guillaume T Vallet Journal: BMJ Open Date: 2022-07-01 Impact factor: 3.006
Authors: Jordan M Jackson; Allison A Bay; Jolie Denise Barter; Liang Ni; William Michael Caudle; Monica C Serra; Whitney Wharton; Madeleine E Hackney Journal: J Alzheimers Dis Rep Date: 2020-08-28
Authors: Pui Hing Chau; Yan Yan Jojo Kwok; Mee Kie Maggie Chan; Ka Yu Daniel Kwan; Kam Lun Wong; Ying Ho Tang; Kan Lung Peter Chau; Sheung Wa Matthew Lau; Yan Yan Yannex Yiu; Mei Yan Fanny Kwong; Wai Ting Thomas Lai; Mun Kit Leung Journal: J Med Internet Res Date: 2021-05-04 Impact factor: 5.428
Authors: Adrian Wong; Stanley Yiu; Ziad Nasreddine; Kam-Tat Leung; Alexander Lau; Yannie O Y Soo; Lawrence Ka-Sing Wong; Vincent Mok Journal: PLoS One Date: 2018-05-23 Impact factor: 3.240